Martin Wolkersdorfer

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

S. Kahl, Sofiya Gancheva, Klaus Straßburger et al. · Diabetes Care · 2019 · 343 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Molecular Cloning and Characterization of NESP55, a Novel Chromogranin-like Precursor of a Peptide with 5-HT1B Receptor Antagonist Activity

Rudolf Ischia, Paola Lovisetti‐Scamihorn, Ruth Hogue‐Angeletti et al. · Journal of Biological Chemistry · 1997 · 195 citations · Full text

Medicine, Molecular Biology, Pharmacology +15

Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial

Yanislava Karusheva, Theresa Koessler, Klaus Straßburger et al. · American Journal of Clinical Nutrition · 2019 · 175 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen–related apple allergy

Tamar Kinaciyan, Birgit Nagl, Sandra Faustmann et al. · Journal of Allergy and Clinical Immunology · 2017 · 75 citations

Life Sciences, Dermatology, Immunology +17

Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial

Verena Wally, Alain Hovnanian, Juliette Ly et al. · Journal of the American Academy of Dermatology · 2018 · 69 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13